Blood Cancer Talks

By Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward CliffMedicine Health & Fitness Education

Blood Cancer Talks episodes

September 14, 2022 Episode 5. Mentorship and Career Development
In this episode, we do a thought provoking discussion with Dr. Marty Tallman on mentorship and career development in academic hematology and medical oncology. A must listen for all trainees and early career clinical investigators. Sage wisdom from a legend in the field!
41 min
August 24, 2022 Episode 4. Measurable Residual Disease in AML
2021 European LeukemiaNET MRD Working Party Consensus Guidelines: https://pubmed.ncbi.nlm.nih.gov/34724563/
Pre-MEASURE Study ASCO 2022: https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.7006
1 hr 3 min
August 10, 2022 Episode 3. Management of Waldenström Macroglobulinemia
https://ascopubs.org/doi/abs/10.1200/JCO.22.00495
47 min
July 27, 2022 Episode 2. CAR T-Cell Therapy in Multiple Myeloma
In this episode, we discuss with Dr. Surbhi Sidana the latest advances, practical aspects of patient management, and future directions of cellular therapies in multiple myeloma.
32 min
July 15, 2022 Episode 1. Implications of Clonal Hematopoiesis
In this episode, we bring two experts in clonal hematopoiesis, Dr. Sid Jaiswal from Stanford University and Dr. Alex Bick from Vanderbilt University to dissect the biology, potential clinical implications, and future of clonal hematopoiesis.
51 min
July 08, 2022 Introduction to BloodCancerTalks
BloodCancerTalks is a new podcast focusing exclusively on hematologic malignancies. We will bring a wide range of experts to dig deep into specific topics and critically appraise the literature.
Raj Chakraborty is a hematologist/oncologist and an Assistant Professor of Medicine at Columbia University. Ash Kishtagari is a hematologist/oncologist and an Assistant Professor of Medicine at Vanderbilt University.
3 min

About Blood Cancer Talks

From the publisher's feed

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.